• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的地理分布:综述

The geographic distribution of multiple sclerosis: a review.

作者信息

Ebers G C, Sadovnick A D

出版信息

Neuroepidemiology. 1993;12(1):1-5. doi: 10.1159/000110293.

DOI:10.1159/000110293
PMID:8327018
Abstract

The decisive conclusions to be drawn from the geography and prevalence of MS are: (1) a north-south (as well as west-east in the United States) gradient exists independent from genetic/racial factors; (2) major differences in prevalence occur in the absence of difference in latitude; (3) individuals from the same ethnic derivation have either the similar prevalence or have very different prevalence rates in widely separated geographical areas, and (4) specific resistance isolates are shown to exist regardless of latitude. Existing prevalence information leads to the almost inescapable conclusion that the geography of MS cannot be explained by any single known environmental or genetic factor(s) in isolation. A combination of a heterogeneous distribution of both genetic and environmental factors appears to be required to explain the available data on MS and geography.

摘要

从多发性硬化症的地理分布和患病率中得出的决定性结论是

(1)存在一个独立于遗传/种族因素的南北梯度(在美国还有东西梯度);(2)在纬度没有差异的情况下,患病率存在重大差异;(3)来自同一族裔的个体在广泛分隔的地理区域中,患病率要么相似,要么差异很大;(4)无论纬度如何,都显示存在特定的抗性隔离区。现有的患病率信息几乎不可避免地得出这样的结论:多发性硬化症的地理分布无法用任何单一已知的环境或遗传因素单独解释。似乎需要遗传和环境因素的异质分布相结合,才能解释关于多发性硬化症和地理分布的现有数据。

相似文献

1
The geographic distribution of multiple sclerosis: a review.多发性硬化症的地理分布:综述
Neuroepidemiology. 1993;12(1):1-5. doi: 10.1159/000110293.
2
Epidemiology of multiple sclerosis: a critical overview.多发性硬化症的流行病学:批判性综述。
Can J Neurol Sci. 1993 Feb;20(1):17-29. doi: 10.1017/s0317167100047351.
3
Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.通过紫外线暴露解释多发性硬化症患病率:一项地理空间分析。
Mult Scler. 2009 Aug;15(8):891-8. doi: 10.1177/1352458509105579.
4
The prevalence of multiple sclerosis in the world: an update.全球多发性硬化症患病率:最新情况
Neurol Sci. 2001 Apr;22(2):117-39. doi: 10.1007/s100720170011.
5
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.地磁扰动可能是多发性硬化症的环境风险因素:24 个国家 111 个地点的生态学研究。
BMC Neurol. 2012 Sep 24;12:100. doi: 10.1186/1471-2377-12-100.
6
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.纬度与多发性硬化症的患病率显著相关:一项荟萃分析。
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1132-41. doi: 10.1136/jnnp.2011.240432. Epub 2011 Apr 8.
7
Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.爱尔兰多发性硬化症患病率的纬度变化:遗传多样性的影响
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):572-6. doi: 10.1136/jnnp.2003.012666.
8
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.澳大利亚的多发性硬化症流行病学。附新南威尔士州和南澳大利亚州的调查结果。
Med J Aust. 1994 Feb 7;160(3):117-22.
9
[Epidemiology of multiple sclerosis: environmental factors versus genetic factors].[多发性硬化症的流行病学:环境因素与遗传因素]
Nihon Rinsho. 2003 Aug;61(8):1300-10.
10
A reassessment of the distribution of multiple sclerosis. Part one.多发性硬化症分布的重新评估。第一部分。
Acta Neurol Scand. 1975 Feb;51(2):110-36. doi: 10.1111/j.1600-0404.1975.tb01364.x.

引用本文的文献

1
Readmission Rates in Patients With Multiple Sclerosis: A Nationwide Cohort Study.多发性硬化症患者的再入院率:一项全国性队列研究。
Int J MS Care. 2022 Sep-Oct;24(5):218-223. doi: 10.7224/1537-2073.2021-089. Epub 2022 May 3.
2
Assessing the Safety of COVID-19 Vaccines: A Primer.评估 COVID-19 疫苗的安全性:入门介绍。
Drug Saf. 2020 Dec;43(12):1205-1210. doi: 10.1007/s40264-020-01002-6. Epub 2020 Sep 30.
3
Clinical trials in multiple sclerosis: potential future trial designs.多发性硬化症的临床试验:未来可能的试验设计
Ther Adv Neurol Disord. 2019 May 13;12:1756286419847095. doi: 10.1177/1756286419847095. eCollection 2019.
4
Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis.昼夜节律基因ARNTL/BMAL1和CLOCK与多发性硬化症的关联。
PLoS One. 2018 Jan 11;13(1):e0190601. doi: 10.1371/journal.pone.0190601. eCollection 2018.
5
Viral-induced suppression of self-reactive T cells: Lessons from neurotropic coronavirus-induced demyelination.病毒诱导的自身反应性T细胞抑制:嗜神经性冠状病毒诱导脱髓鞘的启示。
J Neuroimmunol. 2017 Jul 15;308:12-16. doi: 10.1016/j.jneuroim.2017.01.003. Epub 2017 Jan 11.
6
Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.触珠蛋白等位基因的地理分布与多发性硬化症(MS)患病率的相关性——一篇叙述性文献综述
Metab Brain Dis. 2017 Feb;32(1):19-34. doi: 10.1007/s11011-016-9923-x. Epub 2016 Nov 2.
7
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.紫外线对HLA-II类转基因小鼠免疫反应的调节作用
Jacobs J Allergy Immunol. 2014 Dec;1(1).
8
Gender and uveitis in patients with multiple sclerosis.多发性硬化症患者的性别与葡萄膜炎
J Ophthalmol. 2014;2014:565262. doi: 10.1155/2014/565262. Epub 2014 May 7.
9
Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?新诊断多发性硬化症患者的血清维生素D水平与残疾有关吗?
Iran J Neurol. 2013;12(2):41-6.
10
Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.血清25(OH)维生素D3浓度与多发性硬化严重程度的关联
Iran J Neurol. 2012;11(2):54-8.